ARTICLE | Clinical News
AirFluSal Forspiro salmeterol/fluticasone regulatory update
February 17, 2014 8:00 AM UTC
Novartis' Sandoz generic pharmaceuticals division said Norway and Belgium approved AirFluSal Forspiro salmeterol/fluticasone to treat patients >=12 years with asthma or chronic obstructive pulmonary d...